The Tumor Marker Innovation team is made up of experts in the field of bio-markers. Every day, Dr. Rafael Molina Porto, evaluates more than 250 patients / day and has participated in the Tumor Committees for more than 25 years. He is the author of more than 200 original works, including clinical guidelines for the use of tumor bio-markers, both in Europe (EGTM: European Group on Tumor Markers), the United States (National Academy of Clinical Biochemistry) and Spain (Spanish Society of Biochemistry and Molecular Biology).
He has participated in the organization of more than 20 courses, in Spain (15 courses), in Europe (Berlin, Rome), Latin America (Sao Paolo, Viña del Mar), and Asia (Shanghai, Seoul and Hong Kong). He has been a member of the Organizatory Committee of 26 International Congresses or Symposiums and is President and member of the Board of Societies dedicated to the study of Bio-Markers such as the ISOBM (International Society of Oncology and Biomarkers) or EGTM.